fluorescein-5-isothiocyanate has been researched along with arginyl-glycyl-aspartyl-phenylalanine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jackson, K; McKee, PA; Posan, E; Rak, K; Schwartzott, D; Udvardy, M | 1 |
Andronati, SA; Kabanov, VM; Kabanova, TA; Krysko, AA; Krysko, OL | 1 |
Gan, Z; Zhang, G; Zhou, D | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and arginyl-glycyl-aspartyl-phenylalanine
Article | Year |
---|---|
RGDFAP: platelet aggregation inhibitory and profibrinolytic hybrid peptide (RGDF coupled with the carboxy terminal part of alpha 2-antiplasmin) enhances plasminogen binding to platelets.
Topics: alpha-2-Antiplasmin; Amino Acid Sequence; Blood Platelets; Fibrinolysis; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Molecular Sequence Data; Oligopeptides; Peptides; Plasminogen; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Multimerization | 1995 |
Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.
Topics: Fibrinogen; Fluorescein-5-isothiocyanate; Humans; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Tetrahydroisoquinolines | 2010 |
c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Humans; Micelles; Oligopeptides; Polyesters; Urinary Bladder; Urinary Bladder Neoplasms | 2013 |